title: Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine.
authors.affiliation: Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium. Electronic address: pierre.vandamme@uantwerp.be.
authors.forename: Pierre
authors.initials: P
authors.lastname: Van Damme
authors.affiliation: Department of Pathology, Cambridge University, Cambridge, UK.
authors.forename: Margaret
authors.initials: M
authors.lastname: Stanley
mesh_terms: D000367:Age Factors; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D014612:Vaccines
chemical_list: D014612:Vaccines